Position
SIMPLEX TRADING, LLC in Rapport Therapeutics, Inc.
Back to the book · All holders of RAPP
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $26$30.33 → $31.29
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 27 | $819 | — | — | — | 0.0% |
| Q1 2026 | 344 | $10.8K | $31.29 | $26 | $9.92K | 0.0% |